Skip to main content
. Author manuscript; available in PMC: 2021 Nov 2.
Published in final edited form as: Stem Cell Res. 2021 Sep 11;56:102536. doi: 10.1016/j.scr.2021.102536
Unique stem cell lines identifier ULLi002-A-49
ULLi002-A-51
Institution University of Louisiana at Lafayette, LA USA
Contact information of the reported cell line distributor Baojin Ding (Baojin.Ding@Louisiana.edu)
Type of cell lines iPSC
Origin Human
Additional origin info (applicable for human ESC or iPSC) Age: 30 YR
Sex: Male
Ethnicity: Asian
Cell Source Skin fibroblasts.
Method of reprogramming N/A
Clonality Clonal
Evidence of the reprogramming transgene loss (including genomic copy if applicable) RT/q-PCR
Cell culture system used Serum-free and feeder-free medium
Type of Genetic Modification Induced mutation
Associated disease DYT1 dystonia
Gene/locus TOR1A c.907_909delGAG (p.Glu303del)/9q34.11
Multiline rationale Isogenic clones carrying heterozygous or homozygous of the same gene mutation.
Method of modification/site-specific nuclease used CRISPR/Cas9
Site-specific nuclease (SSN) delivery method Electroporated with a 4D-Nucleofector (Lonza) using CA-137 program.
All genetic material introduced into the cells gRNA vector MLM3636 (Addgene #43860)
Cas9 vector p3s-Cas9HC (Addgene #43945)
Unique stem cell lines identifier ULLi002-A-49
ULLi002-A-51
Analysis of the nuclease-targeted allele status Sequencing of the targeted allele
Method of the off-target nuclease activity surveillance Targeted PCR/sequencing
Name of transgene N/A
Eukaryotic selective agent resistance (including inducible/gene expressing cell-specific) N/A
Inducible/constitutive system details N/A
Date archived/stock date 4/29/2021
Cell line repository/bank https://hpscreg.eu/cell-line/ULLi002-A-49
https://hpscreg.eu/cell-line/ULLi002-A-51
Ethical/GMO work approvals Genetic modification was performed at Genome Engineering and iPSC Center (GEiC) at Washington University in St. Louis.
Addgene/public access repository recombinant DNA sources’ disclaimers (if applicable) N/A